Skip to main content
. 2019 Jan 22;88(1):10–14.

Table 1.

SUMMARY OF THE RESULTS OF THE USE OF SELF EXPANDING STENTS AS A BRIDGE TO SURGERY IN OESOPHAGEAL CANCER

Author Year Type of stent Number of patients Number who had surgical resection (%) Number of stent related complications (%)
Mariette5 2014 SEMS 38 38 (100%) Not reported
Krokidis4 2013 SEPS 11 1 (9%) 5 (45%)
Pellen10 2012 SEMS 16 10 (63%) 8 (50%)
Siddiqui11 2012 SEMS 55 8 (15%) 19 (35%)
Brown12 2011 SEPS 32 20 (63%) 10 (31%)
Lopes13 2010 SEMS 11 2 (18%) 5 (45%)
Langer14 2010 SEMS-25, SEPS-13 38 20 (53%) 18 (47%)
Adler15 2009 SEPS 13 3 (23%) 6 (46%)
Bower3 2009 SEPS 25 14 (56%) 6 (24%)
Martin16 2009 SEPS 5 Not reported 1 (20%)
Siddiqui4 2009 SEPS 12 Not reported 4 (33%)
Griffiths17 2012 BDS 9 3 (33%) 3 (33%)
Kjaer18 2016 SEMS 63 All R0 (this was the group from which the patients who had stents were identified) Not reported
Park19 2015 REMS 25 Not reported Not reported
Van den Berg20 2014 BDS 10 7 (70%) 7 (70%)
Siddiqui21 2007 SEPS 6 100% 3 (60%)

SEMS = Self expanding metal stent;

SEPS = Self expanding plastic stent,

BDS = Biodegradable stent,

REMS = Retrievable expandable metallic stent